EP3346912A4 - Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health - Google Patents
Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health Download PDFInfo
- Publication number
- EP3346912A4 EP3346912A4 EP16845218.3A EP16845218A EP3346912A4 EP 3346912 A4 EP3346912 A4 EP 3346912A4 EP 16845218 A EP16845218 A EP 16845218A EP 3346912 A4 EP3346912 A4 EP 3346912A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- cerebro
- microbiome
- therapeutics
- conditions associated
- derived diagnostics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/70—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Theoretical Computer Science (AREA)
- Public Health (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Primary Health Care (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Artificial Intelligence (AREA)
- Software Systems (AREA)
- Zoology (AREA)
- Evolutionary Computation (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Pathology (AREA)
- Bioethics (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Social Psychology (AREA)
- Developmental Disabilities (AREA)
- Child & Adolescent Psychology (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562216035P | 2015-09-09 | 2015-09-09 | |
US201562216016P | 2015-09-09 | 2015-09-09 | |
US201562215939P | 2015-09-09 | 2015-09-09 | |
US201562216028P | 2015-09-09 | 2015-09-09 | |
US201562216042P | 2015-09-09 | 2015-09-09 | |
PCT/US2016/051155 WO2017044885A1 (en) | 2015-09-09 | 2016-09-09 | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3346912A1 EP3346912A1 (en) | 2018-07-18 |
EP3346912A4 true EP3346912A4 (en) | 2019-08-21 |
Family
ID=58240338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16845218.3A Pending EP3346912A4 (en) | 2015-09-09 | 2016-09-09 | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3346912A4 (en) |
CN (1) | CN108348167B (en) |
AU (1) | AU2016321333A1 (en) |
CA (1) | CA3006044A1 (en) |
WO (1) | WO2017044885A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10395777B2 (en) | 2014-10-21 | 2019-08-27 | uBiome, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
CA2962466C (en) | 2014-10-21 | 2023-01-10 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
US10777320B2 (en) | 2014-10-21 | 2020-09-15 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions |
US10366793B2 (en) | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
WO2018094376A1 (en) * | 2016-11-21 | 2018-05-24 | uBiome, Inc. | Method and system for characterizing a headache-related condition |
EP3769321A1 (en) * | 2017-06-02 | 2021-01-27 | Psomagen, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
US11154240B2 (en) | 2019-04-02 | 2021-10-26 | Kpn Innovations Llc | Methods and systems for utilizing diagnostics for informed vibrant constitutional guidance |
US11289206B2 (en) | 2020-06-02 | 2022-03-29 | Kpn Innovations, Llc. | Artificial intelligence methods and systems for constitutional analysis using objective functions |
US11211158B1 (en) | 2020-08-31 | 2021-12-28 | Kpn Innovations, Llc. | System and method for representing an arranged list of provider aliment possibilities |
CN113096818B (en) * | 2021-04-21 | 2023-05-30 | 西安电子科技大学 | Method for evaluating occurrence probability of acute diseases based on ODE and GRUD |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013176774A1 (en) * | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
US20140301995A1 (en) * | 2011-10-12 | 2014-10-09 | Gut Guide Oy | Raising and Diagnosing of Serotonin Level |
WO2014179965A1 (en) * | 2013-05-09 | 2014-11-13 | The Procter & Gamble Company | Biomarker identifying method and system |
US20150211078A1 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
WO2016065075A1 (en) * | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
US20160232280A1 (en) * | 2014-10-21 | 2016-08-11 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060228721A1 (en) * | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
EP2201134B1 (en) * | 2007-09-19 | 2018-11-21 | The Research Foundation of State University of New York | Gene expression signatures in enriched tumor cell samples |
GB2477439B (en) * | 2008-11-07 | 2012-02-15 | Sequenta Inc | Methods for correlating clonotypes with a disease in a patient |
WO2011022660A1 (en) * | 2009-08-21 | 2011-02-24 | Puretech Ventures, Llc | Methods of diagnosing and treating microbiome-associated disease using interaction network parameters |
KR102042253B1 (en) * | 2010-05-25 | 2019-11-07 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Bambam: parallel comparative analysis of high-throughput sequencing data |
JP2013544507A (en) * | 2010-10-27 | 2013-12-19 | カンティバクト・アクティーゼルスカブ | Capture of target DNA and RNA by probes containing intercalator molecules |
US9689044B2 (en) * | 2011-01-26 | 2017-06-27 | The Brigham And Women's Hospital, Inc. | Assays and methods to sequence microbes directly from immune complexes |
HUE037095T2 (en) * | 2011-03-09 | 2018-08-28 | Cell Signaling Technology Inc | Methods and reagents for creating monoclonal antibodies |
US20130121968A1 (en) * | 2011-10-03 | 2013-05-16 | Atossa Genetics, Inc. | Methods of combining metagenome and the metatranscriptome in multiplex profiles |
SG11201405783VA (en) * | 2012-03-17 | 2014-10-30 | Univ California | Fast diagnosis and personalized treatments for acne |
CN103374518B (en) * | 2012-04-12 | 2018-03-27 | 维里纳塔健康公司 | Copy the detection and classification of number variation |
ES2905448T3 (en) * | 2012-05-10 | 2022-04-08 | Massachusetts Gen Hospital | Methods for determining a nucleotide sequence |
PT2800811T (en) * | 2012-05-25 | 2017-08-17 | Univ California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
US20150125438A1 (en) * | 2012-07-20 | 2015-05-07 | Sang Jae Kim | Anti-Inflammatory Peptides and Composition Comprising the Same |
CN104540962B (en) * | 2012-08-01 | 2017-09-19 | 深圳华大基因研究院 | Diabetes biomarker and its application |
JP6479685B2 (en) * | 2013-02-04 | 2019-03-06 | セレス セラピューティクス インコーポレイテッド | Compositions and methods for the control of pathogenic bacterial growth |
US10253377B2 (en) * | 2013-04-05 | 2019-04-09 | Wayne State University | Systems and methods to assess microbiomes and treatments thereof |
WO2015074054A1 (en) * | 2013-11-18 | 2015-05-21 | The Trustees Of Columbia University In The City Of New York | Improving microbial fitness in the mammalian gut |
CN104195145B (en) * | 2014-07-15 | 2017-01-18 | 浙江大学 | Biomarker of liver cirrhosis, and application thereof |
US10265009B2 (en) * | 2014-10-21 | 2019-04-23 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features |
-
2016
- 2016-09-09 CN CN201680065085.9A patent/CN108348167B/en active Active
- 2016-09-09 EP EP16845218.3A patent/EP3346912A4/en active Pending
- 2016-09-09 WO PCT/US2016/051155 patent/WO2017044885A1/en active Application Filing
- 2016-09-09 CA CA3006044A patent/CA3006044A1/en active Pending
- 2016-09-09 AU AU2016321333A patent/AU2016321333A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140301995A1 (en) * | 2011-10-12 | 2014-10-09 | Gut Guide Oy | Raising and Diagnosing of Serotonin Level |
WO2013176774A1 (en) * | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
WO2014179965A1 (en) * | 2013-05-09 | 2014-11-13 | The Procter & Gamble Company | Biomarker identifying method and system |
US20150211078A1 (en) * | 2014-01-25 | 2015-07-30 | uBiome, Inc. | Method and system for microbiome analysis |
WO2016065075A1 (en) * | 2014-10-21 | 2016-04-28 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
US20160232280A1 (en) * | 2014-10-21 | 2016-08-11 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions |
Non-Patent Citations (1)
Title |
---|
See also references of WO2017044885A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP3346912A1 (en) | 2018-07-18 |
AU2016321333A1 (en) | 2018-04-26 |
CA3006044A1 (en) | 2017-03-16 |
CN108348167A (en) | 2018-07-31 |
CN108348167B (en) | 2022-06-03 |
WO2017044885A1 (en) | 2017-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3347495A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health | |
EP3209803A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics | |
EP3347496A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for oral health | |
EP3317428A4 (en) | Method and system for diagnostic testing | |
EP3333660A4 (en) | Abnormality predictor diagnosis system and abnormality predictor diagnosis method | |
EP3346912A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health | |
EP3283086A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features | |
EP3090416A4 (en) | Method and system for monitoring | |
EP3347367A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis | |
EP3333661A4 (en) | Abnormality predictor diagnosis system and abnormality predictor diagnosis method | |
EP3328273A4 (en) | Method and system for monitoring and improving attention | |
EP3346910A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for eczema | |
EP3299918A4 (en) | Abnormality diagnosis system and abnormality diagnosis method | |
EP3229093A4 (en) | Abnormality diagnosis method and abnormality diagnosis system | |
EP3273648A4 (en) | System and method | |
EP3283085A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features | |
EP3283648A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues | |
EP3346911A4 (en) | Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage | |
EP3105965A4 (en) | System and method for connection rehoming | |
EP3283084A4 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions | |
EP3283650A4 (en) | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features | |
EP3111700A4 (en) | System and method for ue-specific offloading | |
EP3283649A4 (en) | Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions | |
EP3120162A4 (en) | System and method for performing transformer diagnostics | |
EP3335380A4 (en) | Method and system for transaction diagnostics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180406 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G16B 20/00 20190101ALI20190410BHEP Ipc: G16B 40/20 20190101ALI20190410BHEP Ipc: C12Q 1/68 20180101ALI20190410BHEP Ipc: G16H 50/20 20180101AFI20190410BHEP Ipc: G16H 50/70 20180101ALI20190410BHEP Ipc: A61B 5/00 20060101ALI20190410BHEP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R079 Free format text: PREVIOUS MAIN CLASS: A61B0005000000 Ipc: G16H0050200000 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190718 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61B 5/00 20060101ALI20190712BHEP Ipc: C12Q 1/68 20180101ALI20190712BHEP Ipc: G16H 50/70 20180101ALI20190712BHEP Ipc: G16B 20/00 20190101ALI20190712BHEP Ipc: G16B 40/20 20190101ALI20190712BHEP Ipc: G16H 50/20 20180101AFI20190712BHEP |
|
19U | Interruption of proceedings before grant |
Effective date: 20191011 |
|
19W | Proceedings resumed before grant after interruption of proceedings |
Effective date: 20201201 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PSOMAGEN, INC. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20231122 |